全文获取类型
收费全文 | 3737篇 |
免费 | 211篇 |
国内免费 | 11篇 |
专业分类
耳鼻咽喉 | 39篇 |
儿科学 | 133篇 |
妇产科学 | 53篇 |
基础医学 | 441篇 |
口腔科学 | 190篇 |
临床医学 | 199篇 |
内科学 | 786篇 |
皮肤病学 | 46篇 |
神经病学 | 189篇 |
特种医学 | 124篇 |
外科学 | 579篇 |
综合类 | 76篇 |
一般理论 | 1篇 |
预防医学 | 166篇 |
眼科学 | 329篇 |
药学 | 400篇 |
中国医学 | 22篇 |
肿瘤学 | 186篇 |
出版年
2023年 | 22篇 |
2022年 | 97篇 |
2021年 | 167篇 |
2020年 | 62篇 |
2019年 | 93篇 |
2018年 | 151篇 |
2017年 | 104篇 |
2016年 | 148篇 |
2015年 | 143篇 |
2014年 | 196篇 |
2013年 | 220篇 |
2012年 | 346篇 |
2011年 | 245篇 |
2010年 | 195篇 |
2009年 | 161篇 |
2008年 | 221篇 |
2007年 | 209篇 |
2006年 | 208篇 |
2005年 | 179篇 |
2004年 | 139篇 |
2003年 | 126篇 |
2002年 | 108篇 |
2001年 | 31篇 |
2000年 | 31篇 |
1999年 | 33篇 |
1998年 | 30篇 |
1997年 | 17篇 |
1996年 | 18篇 |
1995年 | 10篇 |
1994年 | 7篇 |
1993年 | 11篇 |
1992年 | 20篇 |
1991年 | 24篇 |
1990年 | 22篇 |
1989年 | 18篇 |
1988年 | 18篇 |
1987年 | 16篇 |
1986年 | 13篇 |
1985年 | 8篇 |
1984年 | 12篇 |
1983年 | 5篇 |
1981年 | 5篇 |
1980年 | 3篇 |
1979年 | 14篇 |
1978年 | 11篇 |
1977年 | 8篇 |
1973年 | 4篇 |
1972年 | 3篇 |
1971年 | 3篇 |
1970年 | 4篇 |
排序方式: 共有3959条查询结果,搜索用时 15 毫秒
1.
Pradeep Balasubramanian M.D. C. R. Srinivas M.D. Pavai Arunachalam M.S. M.Ch. K. S. Thirumurthy M.S. M.Ch. P. R. Rajkumar M.S. M.Ch. H. Manuvidhya M.B.B.S. 《Pediatric dermatology》2015,32(3):e78-e81
We report on a child with several café au lait spots in association with a lumbar lipomeningomyelocele as an apparently new association. Cutaneous markers, the identification of which plays a crucial role in the early diagnosis and management of spinal malformations, can accompany occult spinal dysraphism. Herein we report a case of lumbar lipomeningomyelocele associated with an overlying café au lait spot that served as a marker of occult spinal dysraphism. The patient also had segmental café au lait spots on the face, making the association unique. 相似文献
2.
3.
4.
F. Al-Mufti G. Kaur K. Amuluru J.B. Cooper K. Dakay M. El-Ghanem J. Pisapia C. Muh R. Tyagi C. Bowers C. Cole S. Rosner J. Santarelli S. Mayer C. Gandhi 《AJNR. American journal of neuroradiology》2021,42(5):916
BACKGROUND AND PURPOSE:Embolization of the middle meningeal artery for treatment of refractory or recurrent chronic subdural hematomas has gained momentum during the past few years. Little has been reported on the use of the n-BCA liquid embolic system for middle meningeal artery embolization. We present the technical feasibility of using diluted n-BCA for middle meningeal artery embolization.MATERIALS AND METHODS:We sought to examine the safety and technical feasibility of the diluted n-BCA liquid embolic system for middle meningeal artery embolization. Patients with chronic refractory or recurrent subdural hematomas were prospectively enrolled from September 2019 to June 2020. The primary outcome was the safety and technical feasibility of the use of diluted n-BCA for embolization of the middle meningeal artery. The secondary end point was the efficacy in reducing hematoma volume.RESULTS:A total of 16 patients were prospectively enrolled. Concomitant burr-hole craniotomies were performed in 12 of the 16 patients. Two patients required an operation following middle meningeal artery embolization for persistent symptoms. The primary end point was met in 100% of cases in which there were no intra- or postprocedural complications. Distal penetration of the middle meningeal artery branches was achieved in all the enrolled cases. A 7-day post–middle meningeal artery embolization follow-up head CT demonstrated improvement (>50% reduction in subdural hematoma volume) in 9/15 (60%) patients, with 6/15 (40%) showing an unchanged or stable subdural hematoma. At day 21, available CT scans demonstrated substantial further improvement (>75% reduction in subdural hematoma volume).CONCLUSIONS:Embolization of the middle meningeal artery using diluted n-BCA and ethiodized oil (1:6) is safe and feasible from a technical standpoint. The use of a dextrose 5% bolus improves distal penetration of the glue.Despite traditional treatment with surgical evacuation, chronic subdural hematomas (cSDHs) tend to have an indolent course with frequent recurrences.1 In recent years, embolization of the middle meningeal artery (MMA) for treatment of refractory or recurrent cSDH has gained momentum, with recent literature showing a significant reduction in the size of the cSDH as well as lower rates of recurrence.2 The primary endovascular techniques used to date have involved the use of polyvinyl alcohol particles (PVA) and Onyx liquid embolic (ethylene-vinyl alcohol dissolved in dimethyl-sulfoxide; Medtronic). Another commonly used liquid embolic agent in the neurointerventional area is n-BCA, which is a liquid adhesive that polymerizes rapidly on contact with ionic substances and can be injected to achieve permanent vessel occlusion. The rates of polymerization and flow and the penetration depth can be modified using varying amounts of ethiodized oil as well as concurrent infusion of dextrose 5% in water (D5W) during n-BCA (Trufill, Cordis Neurovascular) injection (D5W-push technique).3 Data on the use of n-BCA as an embolic agent in cases of cSDH are extremely limited. Herein, we sought to study the safety and technical feasibility of using diluted n-BCA for embolization of the MMA for cSDHs. 相似文献
5.
6.
7.
8.
9.
Radhika Srinivasan Raje Nijhawan Upasana Gautam Pradeep Bambery 《Diagnostic cytopathology》1994,10(4):383-384
A case of primary amyloidosis, initially detected by fine-needle aspiration of the liver, is reported here. Amorphous acellular metachromatic material was seen extracellularly in between the hepatocytic cords compressing them. This material showed typical apple-green birefringence under crossed bipolars after alkaline Congo-red staining proved its amyloid nature. It was resistant to potassium permanganate pretreatment, indicating it to be of the AL type. © 1994 Wiley-Liss, Inc. 相似文献
10.
Sanjeev GULATI Sandeep GUPTA Vijay KHER Amit GUPTA Rajesh AHLAWAT Pradeep ARORA 《Nephrology (Carlton, Vic.)》1997,3(4):563-567
Summary: This study compares the outcomes of 229 renal transplants, of which 156 were live related renal transplants done at our centre and 73 unrelated transplants done at other centres but followed up at our centre. All the patients were on triple immunosuppression for periods varying between 9 months and 1 year. Patient characteristics, rejections, infections and 1 and 5 years patient and graft survival were analyzed in the two groups. the outcome of patients who continued on cyclosporine beyond 1 year was compared to those who discontinued cyclosporine at 1 year. Males predominated (191 vs 38) in both groups, while younger patients (<50 years) predominated in live related group (152 vs four). There was no difference in the incidence of infection, rejection, graft dysfunction, graft loss or death between the two groups. the 1 and 5 year patient survival in the related and unrelated group, (93.7% and 71.4% vs and 85% and 66%) and graft survival (90.4% and 69.4% vs 83.3% and 65.4%) were similar. However, in the unrelated group, patients who discontinued cyclosporine had a higher incidence of rejections (38% vs 14%) and graft loss (43% vs 11.8%), while in the related group no such difference was found. It is concluded that 1 and 5 year patient and graft survival is comparable between live related and live unrelated transplantation. However, in the unrelated group it is necessary to continue cyclosporine beyond 1 year in order to achieve comparable results. 相似文献